Klinic Raises $24 Million to Build AI-Powered Specialty Care Access Platform
Klinic, an AI-enabled platform for specialty care access, has raised $24 million in combined seed and Series A funding. The round was co-led by Proofpoint Capital and I2BF Global Ventures, with Dan Goldsmith of Proofpoint Capital and Ilya Golubovich of I2BF joining Klinic’s board of directors.
“I saw this problem through our patients’ health care journeys, through my own family, and then I experienced it myself,” said Avish Bhama, founder and CEO of Klinic. “We are building Klinic to make specialty care access faster, more connected and more affordable for patients.”
Getting specialty care is typically a multistage process: finding an available specialist, confirming insurance coverage, completing diagnostics, obtaining a prescription, securing prior authorization and routing the prescription to the right pharmacy. For many patients, that journey can take weeks or months before treatment begins.
Klinic’s infrastructure has already supported more than 150,000 patients across its care access platform, helping reduce administrative friction across the specialty treatment journey. The company can often help patients connect with an in-network provider with availability within 24 to 48 hours.
Klinic works with a nationwide network of more than 200 providers, 175 health plans and an extended network of approximately 135,000 prescribers. Artificial intelligence and workflow automation help Klinic facilitate provider matching, benefits verification, prior authorization, documentation, patient communications and pharmacy routing.
Unlike point solutions that focus on one step in the care journey, Klinic’s AI is embedded into the operational workflows required to move a patient from search to treatment. The goal is not to replace clinical decision-making, but to reduce the administrative handoffs that delay care and cause patients to fall through the cracks.
“Patients don’t care whether it’s AI or not. They care that someone gets them to the right specialist quickly,” said Ilya Golubovich of I2BF Global Ventures. “What convinced us about Klinic is that the technology is invisible to the patient. It just makes the system work the way it always should have.”
“Specialty care has the medicine, but not always the infrastructure to get patients to it. That gap can mean months of delay, administrative burden and patients falling through the cracks,” said Dan Goldsmith of Proofpoint Capital. “Klinic is the only company that has built the connective layer the system has been missing, and the team’s traction with patients, providers and payers convinced us they can scale it nationally.”
Klinic is also partnering with life sciences companies launching high-cost, high-friction specialty medications. For many pharmaceutical companies, developing the therapy is only half the battle. They also have to ensure eligible patients and providers know the drug exists, understand when it may be appropriate and make it through the insurance and access process required to start treatment.
The new funding will be used to expand Klinic’s provider network, advance product engineering and AI automation, and scale its partner network of life sciences companies.
About Klinic
Klinic is an AI-enabled specialty care access platform helping patients navigate the path from search to treatment. The company combines provider access, payer coverage, prior authorization automation, pharmacy coordination and patient support to reduce friction in high-cost, high-complexity specialty care. Klinic works with patients, providers, payers, pharmacies and life sciences companies to make specialty treatment access faster, more connected and more affordable.
Media Contact
Ana Hryshchenia
press@klinic.com
